COMP <GO>
BRKR vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Bruker Corporation (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: BRKR 3
— JNJ 12
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: BRKR
LAST: $57.07 (-7.95%) • MKT CAP: $9.45B
options-implied-move
6.80%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
options-implied-move
7.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BRKR VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BRKR | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.90% | 67.90% | -22.00 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.30% | 25.50% | -24.20 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 75.7x | 18.5x | +57.20 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 0.46% | 2.97% | -2.51 | JNJ | /fcf-yield <GO> |
| Operating Margin | 2.00% | 34.70% | -32.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -0.20% | 28.50% | -28.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 2.10% | 6.00% | -3.90 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.24% | 0.00% | +0.24 | BRKR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.81 | 5.59 | -2.78 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.80% | 7.20% | -0.40 | BRKR | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.5 | 60.4 | -14.81 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 1.08 | -0.11 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 23.0x | -1.00 | BRKR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.45B | $662.49B | -$653.05B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BRKR REV | JNJ REV | BRKR GROSS % | JNJ GROSS % | BRKR FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.44B | $94.19B | 45.9% | 67.9% | $43.3M | $19.70B |
| FY 2024 | $3.37B | $88.82B | 49.0% | 69.1% | $136.0M | $19.84B |
| FY 2023 | $2.96B | $85.16B | 44.0% | 44.0% | $216.7M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BRKR // BETA 0.97
JNJ // BETA 1.08